Sabella Ohja
Levi Strauss & Co. said Wednesday it expects revenue and earnings to grow in 2023 after beating analysts’ expectations for the final quarter of 2022. Shares of the jeans brand rose 6.4% in after-hours trading.
Ocuphire Pharma Inc. said its APX3330, which treats the eye disease diabetic retinopathy, failed to meet its primary endpoint in a recent study. Shares of the ophthalmic biopharmaceutical company tumbled 31% in after-hours trading.
Magenta Therapeutics Inc. said it paused dosing of MGTA-117 after a participant in a clinical trial died possibly related to the treatment. The trial targets blood and myeloid tumors. Shares of the biotech company fell 25% in after-hours trading.
Las Vegas Sands reported an 11% increase in its fourth-quarter revenue and offered an upbeat outlook for 2023. Chief executive Robert Goldstein said he believed travel and tourism spending would continue to recover this year. Shares rose 4.2 percent in after-hours trading.
Seagate Technology Holdings PLC reported fiscal second-quarter results that topped analysts’ expectations and guided for higher-than-expected third-quarter revenue. Shares of the data storage company rose 7.6% in after-hours trading.
Write to Sabela Ojea at sabela.ojea@wsj.com; @sabelaojeaguix is not following anyone. Autodesk_new
